# Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

> **NCT04107207** · NA · COMPLETED · sponsor: **Georgetown University** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Ginger Kombucha
- **DIETARY_SUPPLEMENT:** Ginger Water

## Key facts

- **NCT ID:** NCT04107207
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-11
- **Primary completion:** 2020-05-20
- **Final completion:** 2020-07-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107207, "Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04107207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*